Navigating False Claims Act Exposure With Confidence
Now more than ever, companies, particularly those in government contracting, healthcare and life sciences, technology, diverse-owned businesses and federally regulated industries, must be vigilant about False Claims Act (FCA) exposure. The Department of Justice (DOJ), backed by state attorneys general and new enforcement initiatives such as the Civil Rights Fraud Initiative and the National Fraud Enforcement Division, is aggressively pursuing government fraud while advancing legislation and enforcement measures to strengthen federal funding and regulatory compliance. Concurrently, enhanced whistleblower incentives have driven a record‐high surge in qui tam suits.
Dechert understands what is at stake. Leveraging the experience, expertise and resources of lawyers, our cross-practice team defends businesses and individuals targeted by whistleblower claims, government investigations and related litigation, staying one step ahead of FCA scrutiny. Former federal prosecutors and government lawyers on our team bring critical insight into how these matters unfold. Whether facing high-stakes investigations, private litigation or cross-border inquiries, our team of experts in FCA law and related U.S. laws help safeguard our clients from potential liability, educate them about compliance risks and successfully guide them out of FCA investigations and prosecutions.
We have advised and defended clients on a myriad of challenges, including, but not limited to:
- State and Federal FCA Actions
- Patent-Related Enforcement (e.g., False-Marking Claims, etc.)
- Dodd-Frank Whistleblower Proceedings
- Foreign Corrupt Practice Act (FCPA) Investigations
- Qui Tam and Compliance Disputes (e.g., Improper Pricing/Reporting, Kickbacks, Off-Label Promotion, Defective Products, etc.)
Through our representation, we have obtained full case dismissals, uncovered employee malfeasance, resolved complex matters without criminal charges and guided clients through comprehensive investigations.